Randomized Phase IIa Clinical Study of an Anti-αvβ6 Monoclonal Antibody in Idiopathic Pulmonary Fibrosis

  • Am J Respir Crit Care Med. 2022 Nov 1;206(9):1166-1168. doi: 10.1164/rccm.202205-0868LE.
Ganesh Raghu  1 ,  Majd Mouded  2 ,  Antje Prasse  3 ,  Christopher Stebbins  2 ,  Guolin Zhao  2 ,  Guochen Song  2 ,  Million Arefayene  2 ,  Shelia M Violette  2 ,  Diana Gallagher  2 ,  Kevin F Gibson  4
Affiliations
  • 1. Center for Interstitial Lung Diseases University of Washington Medical Center Seattle, Washington.
  • 2. Biogen, Inc. Cambridge, Massachusetts.
  • 3. Department of Pneumology Medical School of Hannover Hannover, Germany.
  • 4. Division of Pulmonary, Allergy, and Critical Care Medicine University of Pittsburgh School of Medicine Pittsburgh, Pennsylvania.
PMID: 35830489 DOI: 10.1164/rccm.202205-0868LE
Products